Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Research: Improved CEO-CIO Alignment Will Catalyze Strategic Decisions on AI Adoption
-
Skyward Specialty to Host Third Quarter 2025 Earnings Call Thursday, October 30, 2025
-
NUMERATOR GLP-1 HUB REVEALS PURCHASE TRENDS FROM 30K CONSUMERS
-
Humanitarian Nonprofit Human Appeal USA to Host National Comedy Tour
-
Transactions in connection with share buyback programme
-
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
-
Palisade Bio Granted Canadian Patent Covering Composition of Lead Product Candidate PALI-2108
-
Attention Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX); Humana Inc. (NYSE: HUM); Five Below, Inc. (NASDAQ: FIVE); and Treace Medical Concepts, Inc. (NASDAQ: TMCI): Grabar Law
-
Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025
-
374Water to Host Third Quarter 2025 Results Conference Call on Wednesday, November 12, 2025 at 4:30 p.m. Eastern Time
-
OP Financial Group makes upward revision of its earnings outlook for 2025
-
CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML
-
Denny’s Corporation Announces Timing Of Third Quarter 2025 Results And Conference Call On November 3, 2025
-
ECGI to Generate Recurring Revenue Through a Multi-Million-Dollar, Five-Year Contract
-
Pattern Computer Strengthens Global IP Portfolio for AI-Discovered Cancer Therapy PCI020302
-
Blackboxstocks Inc. (NASDAQ: BLBX) Announces its Merger Target REalloys inks LOI for a 10-Year Offtake Agreement for 15% of Tanbreez Production with Critical Metals Corp. (NASDAQ: CRML) to Strengthen
-
CleanCore Solutions Congratulates House of Doge on Successful Go-Public Transaction and Provides Treasury Update
-
HUHUTECH International Group Inc. Strengthens Presence in Japan with Participation at Kyushu Semiconductor Expo
-
TechForce Robotics Expands Live Pilot Network in Preparation for Commercial Rollout
-
CERo Therapeutics Announces Completion of First Cohort of Phase 1 Clinical Trial of CER-1236 in AML
-
Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer
-
Kratos Unveils Revolutionary Low-Cost Cruise Missile System, “Ragnarök”
-
Landis+Gyr Taps SEALSQ for Enhanced Smart Grid Network Security in North America
-
Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer’s and Traumatic Brain Injury Programs
-
Blink Charging UK Selected by Bradford Council to Support Expansion of Public EV Charging Infrastructure
-
ProQR to Participate in Upcoming Investor Conferences in October 2025
-
American Battery Technology Company Completes All Required NEPA Baseline Studies for its Tonopah Flats Lithium Project, One of the Largest Critical Mineral Lithium Projects in the U.S.
-
Myseum Awarded Israeli Patent for Advanced Digital Privacy Technology
-
VCI Global Issues Full-Year 2025 Guidance with 70% Revenue Growth Target Driven by AI, Cybersecurity, Fintech, and GPU Cloud Expansion
-
Third Millennium Unveils Multi-Technology Readers Combining Card and QR Code Access in One Device
-
Evolution Petroleum to Present at the LD Micro Main Event XIX
-
ASP Isotopes Provides Business Updates
-
MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes
-
Auron Therapeutics to Participate in the 8th Annual Targeted Protein Degradation & Induced Proximity Summit
-
Allanite Rare Earths Processing Breakthrough: Successful Completion of Impurity Removal Neutralization Tests
-
Ferrari N.v.: Periodic Report on the Buyback Program
-
Schouw & Co. share buy-back programme, week 41 2025
-
A Milestone in Home Wellness: Bob and Brad Debut iMaster Pro - Their First 4D Zero-Gravity Massage Chair with Body Scanning
-
Evaxion to present a breadth of data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
-
Trump’s Tariff Threats Send Markets Reeling: Business Model Built to Withstand Global Volatility
-
Apyx Medical Corporation Submits FDA 510(k) for Device Label Expansion of AYON Body Contouring System™ for Power Liposuction
-
TurnOnGreen Teams Up with Kinseth Hospitality to Expand EV Charging Across the Portfolio
-
SELLAS Life Sciences to Present In Vivo Preclinical Data Demonstrating Statistically Significant Survival Benefit of SLS009 in T-Cell Prolymphocytic Leukemia at the European Society for Medical Oncolo
-
Enphase Energy Expands Virtual Power Plant Support Across Europe
-
Soleno Therapeutics Appoints Biopharmaceutical Executive Mark W. Hahn to its Board of Directors
-
Connect Appoints Tre Braquet as Chief Brand & Engagement Officer
-
Excellergy Debuts with $70 Million Series A Financing to Advance First-in-Class Portfolio of Trifunctional Effector Cell Response Inhibitors (ECRIs) for Complete Allergic Control
-
Theriva™ Biologics Announces Upcoming Presentations at Medical Meetings
-
LGI Homes Announces Rivenwick Village: A New Community Offering Townhome Living in Ramsey, MN
-
Hinge Bio Announces FDA Clearance of Investigational New Drug Application for HB2198, a Novel B cell-Depleting Agent, for Patients with Systemic Lupus Erythematosus and Lupus Nephritis
